Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies

A Tzikas, DR Holmes Jr, S Gafoor, CE Ruiz… - Ep …, 2017 - academic.oup.com
… appendage occlusion (LAAO) for ischaemic stroke prevention in atrial fibrillation (AF) …
evaluation of long term anticoagulant therapy with dabigatran etexilate trial, comparing dabigatran

[HTML][HTML] From ancient leech to direct thrombin inhibitors and beyond: New from old

MR Montinari, S Minelli - Biomedicine & pharmacotherapy, 2022 - Elsevier
… is attributable to the Greek poet and physician Nicander of … , developing another oral DTI,
dabigatran etexilate, a small (472 … valves, in rheumatic atrial fibrillation, in the antiphospholipid …

Oral anticoagulant therapy—When art meets science

PL Cîmpan, RI Chira, M Mocan, FP Anton… - Journal of Clinical …, 2019 - mdpi.com
treatment remained the first line of therapy in certain groups of patients, such as those with a
mechanical prosthetic heart valve replacement or atrial fibrillationDabigatran etexilate is a …

Acute Stroke and Atrial Fibrillation: Risk of Incorrect NOAC Dosage When Estimating Renal Function From Plasma Creatinine Only

DC Amoey, J Thranitz, TF Münte, G Royl - Frontiers in Neurology, 2022 - frontiersin.org
… how to start anticoagulant treatment (6), … atrial fibrillation (AF), the current guidelines advise
preferring a non-vitamin K antagonist oral anticoagulant (NOAC) like apixaban, dabigatran, …

P2884 Clinical significance of postoperative atrial arrhythmias in patients who underwent lung transplantation

BG Kim, JS Uhm, PS Yang, HT Yu, TH Kim… - European Heart …, 2018 - academic.oup.com
… ; 2Hygeia Hospital, 3rd Department of Cardiology, Athens, Greece … of dabigatran etexilate
treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry …

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

B Godman, RE Malmström, E Diogene… - Expert review of …, 2015 - Taylor & Francis
Dabigatran to prevent stroke & systemic embolism/clot formation in adult patients with non-valvular
atrial fibrillation … the lowest ex-factory price in either Greece, France, Italy, Portugal or …

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient …

R Ara, A Duarte, S Harnan, J Leaviss, S Palmer… - 2015 - eprints.whiterose.ac.uk
… in cardiac arrhythmia 4.3 Evidence for economic evaluations in cardiac arrhythmia 4.4 …
compared anti-arrhythmic drugs for the treatment of AF and atrial flutter. One of the TAs examined …

Discovery of anticoagulant drugs: a historical perspective

A Gomez-Outes, M Luisa Suarez-Gea… - Current drug …, 2012 - ingentaconnect.com
… last 10 years, and the dominance of atrial fibrillation (AF) among its … The Greek scholar Galen
mentioned the use of them for … dabigatran (BIBR 953) and its prodrug dabigatran etexilate (…

Characteristics of recurrent ischemic stroke after embolic stroke of undetermined source: secondary analysis of a randomized clinical trial

R Veltkamp, LA Pearce, E Korompoki… - JAMA …, 2020 - jamanetwork.com
… Corresponding to the analysis by Healey and colleagues, 12 atrial diameter was larger in …
stroke associated with atrial fibrillation than those without atrial fibrillation in our analysis. …

O PIONEERs! The beginning of the end of full-dose triple therapy with warfarin?

DL Bhatt - Circulation, 2017 - Am Heart Assoc
… trials are evaluating patients with atrial fibrillation undergoing stenting or with acute coronary
syndromes, such as RE-DUAL PCI (Evaluation of Dual Therapy With Dabigatran vs. Triple …